BioVie Inc. Share Price & Technical Analysis
BIVI · $1.52 (+2.70%)
Healthcare / Biotechnology
$1.52
+2.70%
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to mod…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-6% return in May, -4% avg return in past 3 year May month.
27% return in 2026, -139% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -8% | 27% | 0% | 14% | -6% | – | – | – | – | – | – | – | 27% |
| 25 | -20% | -16% | -27% | -15% | 20% | -12% | -33% | -75% | 19% | -5% | -17% | -20% | -202% |
| 24 | -20% | 17% | -82% | -7% | -7% | -12% | -8% | -30% | -56% | 125% | 2% | -30% | -108% |
| 23 | -36% | 52% | 5% | 1% | -25% | -27% | 10% | -33% | 9% | 25% | -60% | -28% | -107% |
| 22 | -32% | -3% | 51% | -22% | -30% | -44% | 49% | 68% | -30% | 77% | 57% | 15% | 154% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$9.88M
P/E ratio
—
52W high
$12.10
52W low
$1.06
Volume
63,469
Beta
0.72
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is BioVie Inc. share price today?
- BioVie Inc. (BIVI) last traded around $1.52 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BIVI have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BIVI. Download the app for real-time alerts.
- How can I analyze BioVie Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.